{"transactions":[{"id":763759,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-26T22:00:32.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":16965,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan."}],"balance_after":32209,"source":{"system":"sec-edgar","filing":"0001756438-26-000003","document":"form4-05262026_060527.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000175643826000003/form4-05262026_060527.xml","form_type":"4"}},{"id":937098,"issuer":{"id":7318,"kind":"organization","name":"InspireMD, Inc.","symbol":"NSPR"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-16T23:09:40.000Z","date":"2026-01-14","kind":"grant","planned":false,"acquired":true,"shares":44030,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock represent shares of restricted stock that shall vest on January 14, 2027 (the \"One Year Grant Anniversary Date\"), subject to the Reporting Person's continued service."}],"balance_after":102047,"source":{"system":"sec-edgar","filing":"0001493152-26-002664","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1433607/000149315226002664/ownership.xml","form_type":"4"}},{"id":939209,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-15T01:30:04.000Z","date":"2026-01-13","kind":"grant","planned":false,"acquired":true,"shares":3997,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan."}],"balance_after":15244,"source":{"system":"sec-edgar","filing":"0001756438-26-000002","document":"form4-01142026_080101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000175643826000002/form4-01142026_080101.xml","form_type":"4"}},{"id":1199823,"issuer":{"id":2350,"kind":"organization","name":"Beta Bionics, Inc.","symbol":"BBNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-19T00:00:12.000Z","date":"2025-03-15","kind":"grant","planned":false,"acquired":true,"shares":11247,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan."}],"balance_after":11247,"source":{"system":"sec-edgar","filing":"0001415889-25-008535","document":"form4-03182025_080306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674632/000141588925008535/form4-03182025_080306.xml","form_type":"4"}},{"id":1766584,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CFO"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2023-10-03T19:37:17.000Z","date":"2023-09-29","kind":"exercise","planned":false,"acquired":false,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2023. The units represented here are pro-rated through the date of separation."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2023. The units represented here are pro-rated through the date of separation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2023. The units represented here are pro-rated through the date of separation."}],"balance_after":0,"derivative":{"exercise_date":"2024-01-31","underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0001562180-23-007190","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218023007190/primarydocument.xml","form_type":"4"}},{"id":1766583,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CFO"}}],"security":"Common Stock","published_at":"2023-10-03T19:37:17.000Z","date":"2023-09-29","kind":"sale","planned":false,"acquired":false,"shares":7675,"price":56.8717,"value":436490.2975,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of Issuer's common stock sold to cover the reporting person's tax obligation in connection with the conversion of the Performance-Based Restricted Stock Units disclosed herein."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $56.51 to $57.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":23777,"source":{"system":"sec-edgar","filing":"0001562180-23-007190","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218023007190/primarydocument.xml","form_type":"4"}},{"id":1766582,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CFO"}}],"security":"Common Stock","published_at":"2023-10-03T19:37:17.000Z","date":"2023-09-29","kind":"exercise","planned":false,"acquired":true,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":31452,"source":{"system":"sec-edgar","filing":"0001562180-23-007190","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218023007190/primarydocument.xml","form_type":"4"}},{"id":1766580,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CFO"}}],"security":"Common Stock","published_at":"2023-10-03T19:32:22.000Z","date":"2022-02-03","kind":"sale","planned":false,"acquired":false,"shares":947,"price":49.0347,"value":46435.8609,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares of Issuer's common stock sold to cover the reporting person's tax obligation in connection with the conversion of the Performance-Based Restricted Stock Units disclosed herein."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $48.78 to $49.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amendment is being filed to address an error in reporting the amount of securities beneficially owned following reported transactions on February 3, 2022. Accordingly, this amendment is being filed to amend and restate this line from the Original Form 4 in its entirety. This Form 4 acts as an amendment for all subsequently filed Form 4s."}],"balance_after":39235,"source":{"system":"sec-edgar","filing":"0001562180-23-007189","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218023007189/primarydocument.xml","form_type":"4/A","original_submission_date":"2022-02-03"}},{"id":1766579,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CFO"}}],"security":"Common Stock","published_at":"2023-10-03T19:32:22.000Z","date":"2022-02-03","kind":"sale","planned":false,"acquired":false,"shares":17737,"price":48.2103,"value":855106.0911,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares of Issuer's common stock sold to cover the reporting person's tax obligation in connection with the conversion of the Performance-Based Restricted Stock Units disclosed herein."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $47.76 to $48.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amendment is being filed to address an error in reporting the amount of securities beneficially owned following reported transactions on February 3, 2022. Accordingly, this amendment is being filed to amend and restate this line from the Original Form 4 in its entirety. This Form 4 acts as an amendment for all subsequently filed Form 4s."}],"balance_after":40182,"source":{"system":"sec-edgar","filing":"0001562180-23-007189","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218023007189/primarydocument.xml","form_type":"4/A","original_submission_date":"2022-02-03"}},{"id":1766578,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CFO"}}],"security":"Common Stock","published_at":"2023-10-03T19:32:22.000Z","date":"2022-02-03","kind":"exercise","planned":false,"acquired":true,"shares":36919,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amendment is being filed to address an error in reporting the amount of securities beneficially owned following reported transactions on February 3, 2022. Accordingly, this amendment is being filed to amend and restate this line from the Original Form 4 in its entirety. This Form 4 acts as an amendment for all subsequently filed Form 4s."}],"balance_after":57919,"source":{"system":"sec-edgar","filing":"0001562180-23-007189","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218023007189/primarydocument.xml","form_type":"4/A","original_submission_date":"2022-02-03"}},{"id":1873109,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CFO"}}],"security":"Common Stock","published_at":"2023-05-31T20:01:10.000Z","date":"2023-05-26","kind":"sale","planned":true,"acquired":false,"shares":300,"price":50.14,"value":15042.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":9202,"source":{"system":"sec-edgar","filing":"0001562180-23-004641","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218023004641/primarydocument.xml","form_type":"4"}},{"id":1873108,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CFO"}}],"security":"Common Stock","published_at":"2023-05-31T20:01:10.000Z","date":"2023-05-26","kind":"sale","planned":true,"acquired":false,"shares":7699,"price":49.4355,"value":380603.9145,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $49.09 to $50.025. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":9502,"source":{"system":"sec-edgar","filing":"0001562180-23-004641","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218023004641/primarydocument.xml","form_type":"4"}},{"id":1913963,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CFO"}}],"security":"Stock Options (Right to buy)","published_at":"2023-04-25T20:06:32.000Z","date":"2023-04-21","kind":"exercise","planned":true,"acquired":false,"shares":13208,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on January 30, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on January 1, 2023, provided the reporting person remains in continuous service on each vesting date."}],"balance_after":0,"derivative":{"exercise_price":14.19,"expiration_date":"2029-01-30","underlying":"Common Stock","underlying_shares":13208},"source":{"system":"sec-edgar","filing":"0001562180-23-003685","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218023003685/primarydocument.xml","form_type":"4"}},{"id":1913962,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CFO"}}],"security":"Common Stock","published_at":"2023-04-25T20:06:32.000Z","date":"2023-04-21","kind":"sale","planned":true,"acquired":false,"shares":9637,"price":60.5037,"value":583074.1569,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $60.22 to $61.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":17201,"source":{"system":"sec-edgar","filing":"0001562180-23-003685","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218023003685/primarydocument.xml","form_type":"4"}},{"id":1913961,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CFO"}}],"security":"Common Stock","published_at":"2023-04-25T20:06:32.000Z","date":"2023-04-21","kind":"sale","planned":true,"acquired":false,"shares":10363,"price":59.9308,"value":621062.8804,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $59.22 to $60.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":26838,"source":{"system":"sec-edgar","filing":"0001562180-23-003685","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218023003685/primarydocument.xml","form_type":"4"}},{"id":1913960,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CFO"}}],"security":"Common Stock","published_at":"2023-04-25T20:06:32.000Z","date":"2023-04-21","kind":"exercise","planned":true,"acquired":true,"shares":13208,"price":14.19,"value":187421.52,"ownership":{"direct":true},"balance_after":37201,"source":{"system":"sec-edgar","filing":"0001562180-23-003685","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218023003685/primarydocument.xml","form_type":"4"}},{"id":1914773,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CFO"}}],"security":"Stock Options (Right to buy)","published_at":"2023-04-24T20:35:19.000Z","date":"2023-04-20","kind":"exercise","planned":true,"acquired":false,"shares":2001,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on January 30, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on January 1, 2023, provided the reporting person remains in continuous service on each vesting date."}],"balance_after":13208,"derivative":{"exercise_price":14.19,"expiration_date":"2029-01-30","underlying":"Common Stock","underlying_shares":2001},"source":{"system":"sec-edgar","filing":"0001562180-23-003669","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218023003669/primarydocument.xml","form_type":"4"}},{"id":1914772,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CFO"}}],"security":"Common Stock","published_at":"2023-04-24T20:35:19.000Z","date":"2023-04-20","kind":"sale","planned":true,"acquired":false,"shares":2001,"price":60.0063,"value":120072.6063,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $60.00 to $60.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":23993,"source":{"system":"sec-edgar","filing":"0001562180-23-003669","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218023003669/primarydocument.xml","form_type":"4"}},{"id":1914771,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CFO"}}],"security":"Common Stock","published_at":"2023-04-24T20:35:19.000Z","date":"2023-04-20","kind":"exercise","planned":true,"acquired":true,"shares":2001,"price":14.19,"value":28394.19,"ownership":{"direct":true},"balance_after":25994,"source":{"system":"sec-edgar","filing":"0001562180-23-003669","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218023003669/primarydocument.xml","form_type":"4"}},{"id":1926772,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CFO"}}],"security":"Stock Options (Right to buy)","published_at":"2023-04-04T20:24:29.000Z","date":"2023-03-31","kind":"exercise","planned":true,"acquired":false,"shares":2899,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on March 30, 2018, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of March 30, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.63,"expiration_date":"2028-03-30","underlying":"Common Stock","underlying_shares":2899},"source":{"system":"sec-edgar","filing":"0001562180-23-003425","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218023003425/primarydocument.xml","form_type":"4"}},{"id":1926771,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CFO"}}],"security":"Stock Options (Right to buy)","published_at":"2023-04-04T20:24:29.000Z","date":"2023-03-31","kind":"exercise","planned":true,"acquired":false,"shares":5468,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on December 12, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on December 1, 2023, provided the reporting person remains in continuous service on each vesting date."}],"balance_after":7032,"derivative":{"exercise_price":25.82,"expiration_date":"2029-12-12","underlying":"Common Stock","underlying_shares":5468},"source":{"system":"sec-edgar","filing":"0001562180-23-003425","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218023003425/primarydocument.xml","form_type":"4"}},{"id":1926770,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CFO"}}],"security":"Stock Options (Right to buy)","published_at":"2023-04-04T20:24:29.000Z","date":"2023-03-31","kind":"exercise","planned":true,"acquired":false,"shares":6633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on January 30, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on January 1, 2023, provided the reporting person remains in continuous service on each vesting date."}],"balance_after":15209,"derivative":{"exercise_price":14.19,"expiration_date":"2029-01-30","underlying":"Common Stock","underlying_shares":6633},"source":{"system":"sec-edgar","filing":"0001562180-23-003425","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218023003425/primarydocument.xml","form_type":"4"}},{"id":1926769,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CFO"}}],"security":"Common Stock","published_at":"2023-04-04T20:24:29.000Z","date":"2023-03-31","kind":"sale","planned":true,"acquired":false,"shares":7802,"price":55.6785,"value":434403.657,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $55.49 to $55.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":23993,"source":{"system":"sec-edgar","filing":"0001562180-23-003425","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218023003425/primarydocument.xml","form_type":"4"}},{"id":1926768,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CFO"}}],"security":"Common Stock","published_at":"2023-04-04T20:24:29.000Z","date":"2023-03-31","kind":"sale","planned":true,"acquired":false,"shares":7198,"price":54.8346,"value":394699.4508,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $54.49 to $55.4839. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":31795,"source":{"system":"sec-edgar","filing":"0001562180-23-003425","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218023003425/primarydocument.xml","form_type":"4"}},{"id":1926767,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CFO"}}],"security":"Common Stock","published_at":"2023-04-04T20:24:29.000Z","date":"2023-03-31","kind":"exercise","planned":true,"acquired":true,"shares":2899,"price":1.63,"value":4725.37,"ownership":{"direct":true},"balance_after":38993,"source":{"system":"sec-edgar","filing":"0001562180-23-003425","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218023003425/primarydocument.xml","form_type":"4"}},{"id":1926766,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CFO"}}],"security":"Common Stock","published_at":"2023-04-04T20:24:29.000Z","date":"2023-03-31","kind":"exercise","planned":true,"acquired":true,"shares":5468,"price":25.82,"value":141183.76,"ownership":{"direct":true},"balance_after":36094,"source":{"system":"sec-edgar","filing":"0001562180-23-003425","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218023003425/primarydocument.xml","form_type":"4"}},{"id":1926765,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CFO"}}],"security":"Common Stock","published_at":"2023-04-04T20:24:29.000Z","date":"2023-03-31","kind":"exercise","planned":true,"acquired":true,"shares":6633,"price":14.19,"value":94122.27,"ownership":{"direct":true},"balance_after":30626,"source":{"system":"sec-edgar","filing":"0001562180-23-003425","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218023003425/primarydocument.xml","form_type":"4"}},{"id":2035120,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CFO"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2023-02-02T20:06:52.000Z","date":"2023-01-31","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F9","text":"The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending January 31, 2023, and provided the reporting person remains in continuous service through January 31, 2023."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending January 31, 2023, and provided the reporting person remains in continuous service through January 31, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending January 31, 2023, and provided the reporting person remains in continuous service through January 31, 2023."}],"balance_after":0,"derivative":{"exercise_date":"2022-01-31","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001562180-23-000874","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218023000874/primarydocument.xml","form_type":"4"}},{"id":2035119,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CFO"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2023-02-02T20:06:52.000Z","date":"2023-01-31","kind":"exercise","acquired":false,"shares":5250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F8","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2022 and provided the reporting person remains in continuous service through January 31, 2023."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2022 and provided the reporting person remains in continuous service through January 31, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2022 and provided the reporting person remains in continuous service through January 31, 2023."}],"balance_after":0,"derivative":{"exercise_date":"2023-01-31","underlying":"Common Stock","underlying_shares":5250},"source":{"system":"sec-edgar","filing":"0001562180-23-000874","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218023000874/primarydocument.xml","form_type":"4"}},{"id":2035118,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CFO"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2023-02-02T20:06:52.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending January 31, 2025, and provided the reporting person remains in continuous service through January 31, 2025."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending January 31, 2025, and provided the reporting person remains in continuous service through January 31, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending January 31, 2025, and provided the reporting person remains in continuous service through January 31, 2025."}],"balance_after":5000,"derivative":{"exercise_date":"2025-01-31","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001562180-23-000874","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218023000874/primarydocument.xml","form_type":"4"}},{"id":2035117,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CFO"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2023-02-02T20:06:52.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2023 and provided the reporting person remains in continuous service through January 31, 2024."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2023 and provided the reporting person remains in continuous service through January 31, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2023 and provided the reporting person remains in continuous service through January 31, 2024."}],"balance_after":15000,"derivative":{"exercise_date":"2024-01-31","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001562180-23-000874","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218023000874/primarydocument.xml","form_type":"4"}},{"id":2035116,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CFO"}}],"security":"Common Stock","published_at":"2023-02-02T20:06:52.000Z","date":"2023-02-01","kind":"sale","acquired":false,"shares":2772,"price":61.016,"value":169136.352,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of Issuer's common stock sold to cover the reporting person's tax obligation in connection with the conversion of the Performance-Based Restricted Stock Units disclosed herein."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $60.85 to $61.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":23993,"source":{"system":"sec-edgar","filing":"0001562180-23-000874","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218023000874/primarydocument.xml","form_type":"4"}},{"id":2035115,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CFO"}}],"security":"Common Stock","published_at":"2023-02-02T20:06:52.000Z","date":"2023-02-01","kind":"sale","acquired":false,"shares":474,"price":60.4347,"value":28646.0478,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of Issuer's common stock sold to cover the reporting person's tax obligation in connection with the conversion of the Performance-Based Restricted Stock Units disclosed herein."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $59.85 to $60.845. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":26765,"source":{"system":"sec-edgar","filing":"0001562180-23-000874","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218023000874/primarydocument.xml","form_type":"4"}},{"id":2035114,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CFO"}}],"security":"Common Stock","published_at":"2023-02-02T20:06:52.000Z","date":"2023-01-31","kind":"sale","acquired":false,"shares":2720,"price":61.1219,"value":166251.568,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of Issuer's common stock sold to cover the reporting person's tax obligation in connection with the conversion of the Performance-Based Restricted Stock Units disclosed herein."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $60.78 to $61.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":27239,"source":{"system":"sec-edgar","filing":"0001562180-23-000874","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218023000874/primarydocument.xml","form_type":"4"}},{"id":2035113,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CFO"}}],"security":"Common Stock","published_at":"2023-02-02T20:06:52.000Z","date":"2023-01-31","kind":"sale","acquired":false,"shares":7791,"price":61.1694,"value":476570.7954,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of Issuer's common stock sold to cover the reporting person's tax obligation in connection with the conversion of the Performance-Based Restricted Stock Units disclosed herein."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $60.78 to $61.595. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":29959,"source":{"system":"sec-edgar","filing":"0001562180-23-000874","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218023000874/primarydocument.xml","form_type":"4"}},{"id":2035112,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CFO"}}],"security":"Common Stock","published_at":"2023-02-02T20:06:52.000Z","date":"2023-01-31","kind":"exercise","acquired":true,"shares":25250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":37750,"source":{"system":"sec-edgar","filing":"0001562180-23-000874","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218023000874/primarydocument.xml","form_type":"4"}},{"id":2035111,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CFO"}}],"security":"Common Stock","published_at":"2023-02-02T20:06:52.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12500,"source":{"system":"sec-edgar","filing":"0001562180-23-000874","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218023000874/primarydocument.xml","form_type":"4"}},{"id":2158155,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-09-15T20:03:53.000Z","date":"2022-09-13","kind":"sale","acquired":false,"shares":656,"price":75.6,"value":49593.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":7500,"source":{"system":"sec-edgar","filing":"0001562180-22-006685","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022006685/primarydocument.xml","form_type":"4"}},{"id":2185339,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Options (Right to buy)","published_at":"2022-08-15T20:34:41.000Z","date":"2022-08-11","kind":"exercise","acquired":false,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on December 12, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on December 1, 2023, provided the reporting person remains in continuous service on each vesting date."}],"balance_after":12500,"derivative":{"exercise_price":25.82,"expiration_date":"2029-12-12","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001562180-22-006102","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022006102/primarydocument.xml","form_type":"4"}},{"id":2185338,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Options (Right to buy)","published_at":"2022-08-15T20:34:41.000Z","date":"2022-08-11","kind":"exercise","acquired":false,"shares":7047,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on January 30, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on January 1, 2023, provided the reporting person remains in continuous service on each vesting date."}],"balance_after":2223,"derivative":{"exercise_price":14.19,"expiration_date":"2029-01-30","underlying":"Common Stock","underlying_shares":7047},"source":{"system":"sec-edgar","filing":"0001562180-22-006102","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022006102/primarydocument.xml","form_type":"4"}},{"id":2185337,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Options (Right to buy)","published_at":"2022-08-15T20:34:41.000Z","date":"2022-08-11","kind":"exercise","acquired":false,"shares":20545,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on March 30, 2018, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of March 30, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.63,"expiration_date":"2028-03-30","underlying":"Common Stock","underlying_shares":20545},"source":{"system":"sec-edgar","filing":"0001562180-22-006102","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022006102/primarydocument.xml","form_type":"4"}},{"id":2185336,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Options (Right to buy)","published_at":"2022-08-15T20:34:41.000Z","date":"2022-08-11","kind":"exercise","acquired":false,"shares":2044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on May 22, 2017, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of May 22, 2017, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.32,"expiration_date":"2027-07-05","underlying":"Common Stock","underlying_shares":2044},"source":{"system":"sec-edgar","filing":"0001562180-22-006102","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022006102/primarydocument.xml","form_type":"4"}},{"id":2185335,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Options (Right to buy)","published_at":"2022-08-15T20:34:41.000Z","date":"2022-08-11","kind":"exercise","acquired":false,"shares":1616,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on July 5, 2017, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of July 5, 2017, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.32,"expiration_date":"2027-05-22","underlying":"Common Stock","underlying_shares":1616},"source":{"system":"sec-edgar","filing":"0001562180-22-006102","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022006102/primarydocument.xml","form_type":"4"}},{"id":2185334,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-08-15T20:34:41.000Z","date":"2022-08-11","kind":"sale","acquired":false,"shares":6960,"price":72.1881,"value":502429.176,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $71.98 to $72.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":8156,"source":{"system":"sec-edgar","filing":"0001562180-22-006102","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022006102/primarydocument.xml","form_type":"4"}},{"id":2185333,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-08-15T20:34:41.000Z","date":"2022-08-11","kind":"sale","acquired":false,"shares":16280,"price":71.2637,"value":1160173.036,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $70.96 to $71.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":15116,"source":{"system":"sec-edgar","filing":"0001562180-22-006102","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022006102/primarydocument.xml","form_type":"4"}},{"id":2185332,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-08-15T20:34:41.000Z","date":"2022-08-11","kind":"sale","acquired":false,"shares":26760,"price":70.3259,"value":1881921.084,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $69.96 to $70.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":31396,"source":{"system":"sec-edgar","filing":"0001562180-22-006102","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022006102/primarydocument.xml","form_type":"4"}},{"id":2185331,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-08-15T20:34:41.000Z","date":"2022-08-11","kind":"exercise","acquired":true,"shares":6250,"price":25.82,"value":161375.0,"ownership":{"direct":true},"balance_after":58156,"source":{"system":"sec-edgar","filing":"0001562180-22-006102","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022006102/primarydocument.xml","form_type":"4"}},{"id":2185330,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-08-15T20:34:41.000Z","date":"2022-08-11","kind":"exercise","acquired":true,"shares":7047,"price":14.19,"value":99996.93,"ownership":{"direct":true},"balance_after":51906,"source":{"system":"sec-edgar","filing":"0001562180-22-006102","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022006102/primarydocument.xml","form_type":"4"}},{"id":2185329,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-08-15T20:34:41.000Z","date":"2022-08-11","kind":"exercise","acquired":true,"shares":20545,"price":1.63,"value":33488.35,"ownership":{"direct":true},"balance_after":44859,"source":{"system":"sec-edgar","filing":"0001562180-22-006102","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022006102/primarydocument.xml","form_type":"4"}},{"id":2185328,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-08-15T20:34:41.000Z","date":"2022-08-11","kind":"exercise","acquired":true,"shares":2044,"price":1.32,"value":2698.08,"ownership":{"direct":true},"balance_after":24314,"source":{"system":"sec-edgar","filing":"0001562180-22-006102","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022006102/primarydocument.xml","form_type":"4"}},{"id":2185327,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-08-15T20:34:41.000Z","date":"2022-08-11","kind":"exercise","acquired":true,"shares":1616,"price":1.32,"value":2133.12,"ownership":{"direct":true},"balance_after":22270,"source":{"system":"sec-edgar","filing":"0001562180-22-006102","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022006102/primarydocument.xml","form_type":"4"}},{"id":2352710,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Options (Right to buy)","published_at":"2022-03-03T19:45:49.000Z","date":"2022-03-01","kind":"exercise","acquired":false,"shares":12329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on December 12, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on December 1, 2023, provided the reporting person remains in continuous service on each vesting date."}],"balance_after":2343,"derivative":{"exercise_price":25.82,"expiration_date":"2029-12-12","underlying":"Common Stock","underlying_shares":12329},"source":{"system":"sec-edgar","filing":"0001562180-22-002348","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022002348/primarydocument.xml","form_type":"4"}},{"id":2352709,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-03-03T19:45:49.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":10564,"price":58.1137,"value":613913.1268,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $57.85 to $58.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":20654,"source":{"system":"sec-edgar","filing":"0001562180-22-002348","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022002348/primarydocument.xml","form_type":"4"}},{"id":2352708,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-03-03T19:45:49.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":7846,"price":57.395,"value":450321.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $56.84 to $57.83. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":31218,"source":{"system":"sec-edgar","filing":"0001562180-22-002348","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022002348/primarydocument.xml","form_type":"4"}},{"id":2352707,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-03-03T19:45:49.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":1500,"price":56.3166,"value":84474.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $55.82 to $56.68. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":39064,"source":{"system":"sec-edgar","filing":"0001562180-22-002348","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022002348/primarydocument.xml","form_type":"4"}},{"id":2352706,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-03-03T19:45:49.000Z","date":"2022-03-01","kind":"exercise","acquired":true,"shares":12329,"price":25.82,"value":318334.78,"ownership":{"direct":true},"balance_after":40564,"source":{"system":"sec-edgar","filing":"0001562180-22-002348","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022002348/primarydocument.xml","form_type":"4"}},{"id":2364340,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Options (Right to buy)","published_at":"2022-03-01T20:13:19.000Z","date":"2022-02-25","kind":"exercise","acquired":false,"shares":3579,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on January 30, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on January 1, 2023, provided the reporting person remains in continuous service on each vesting date."}],"balance_after":6666,"derivative":{"exercise_price":14.19,"expiration_date":"2029-01-30","underlying":"Common Stock","underlying_shares":3579},"source":{"system":"sec-edgar","filing":"0001562180-22-002063","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022002063/primarydocument.xml","form_type":"4"}},{"id":2364339,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Options (Right to buy)","published_at":"2022-03-01T20:13:19.000Z","date":"2022-02-25","kind":"exercise","acquired":false,"shares":6421,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on December 12, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on December 1, 2023, provided the reporting person remains in continuous service on each vesting date."}],"balance_after":14672,"derivative":{"exercise_price":25.82,"expiration_date":"2029-12-12","underlying":"Common Stock","underlying_shares":6421},"source":{"system":"sec-edgar","filing":"0001562180-22-002063","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022002063/primarydocument.xml","form_type":"4"}},{"id":2364338,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-03-01T20:13:19.000Z","date":"2022-02-25","kind":"sale","acquired":false,"shares":10000,"price":57,"value":570000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":28235,"source":{"system":"sec-edgar","filing":"0001562180-22-002063","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022002063/primarydocument.xml","form_type":"4"}},{"id":2364337,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-03-01T20:13:19.000Z","date":"2022-02-25","kind":"exercise","acquired":true,"shares":3579,"price":14.19,"value":50786.01,"ownership":{"direct":true},"balance_after":38235,"source":{"system":"sec-edgar","filing":"0001562180-22-002063","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022002063/primarydocument.xml","form_type":"4"}},{"id":2364336,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-03-01T20:13:19.000Z","date":"2022-02-25","kind":"exercise","acquired":true,"shares":6421,"price":25.82,"value":165790.22,"ownership":{"direct":true},"balance_after":34656,"source":{"system":"sec-edgar","filing":"0001562180-22-002063","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022002063/primarydocument.xml","form_type":"4"}},{"id":2412892,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2022-02-03T21:30:55.000Z","date":"2022-02-03","kind":"exercise","acquired":false,"shares":26086,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F13","text":"The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending December 31, 2021, and provided the reporting person remains in continuous service through December 31, 2021."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F13","text":"The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending December 31, 2021, and provided the reporting person remains in continuous service through December 31, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F13","text":"The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending December 31, 2021, and provided the reporting person remains in continuous service through December 31, 2021."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2021-12-31","underlying":"Common Stock","underlying_shares":26086},"source":{"system":"sec-edgar","filing":"0001562180-22-001105","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022001105/primarydocument.xml","form_type":"4"}},{"id":2412891,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2022-02-03T21:30:55.000Z","date":"2022-02-03","kind":"exercise","acquired":false,"shares":10833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F12","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2021 and provided the reporting person remains in continuous service through January 31, 2022."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F12","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2021 and provided the reporting person remains in continuous service through January 31, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F12","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2021 and provided the reporting person remains in continuous service through January 31, 2022."}],"balance_after":0,"derivative":{"exercise_date":"2022-01-31","underlying":"Common Stock","underlying_shares":10833},"source":{"system":"sec-edgar","filing":"0001562180-22-001105","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022001105/primarydocument.xml","form_type":"4"}},{"id":2412890,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2022-02-03T21:30:55.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":5250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F11","text":"The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending January 31, 2024, and provided the reporting person remains in continuous service through January 31, 2024."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F11","text":"The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending January 31, 2024, and provided the reporting person remains in continuous service through January 31, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F11","text":"The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending January 31, 2024, and provided the reporting person remains in continuous service through January 31, 2024."}],"balance_after":5250,"derivative":{"exercise_date":"2024-01-31","underlying":"Common Stock","underlying_shares":5250},"source":{"system":"sec-edgar","filing":"0001562180-22-001105","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022001105/primarydocument.xml","form_type":"4"}},{"id":2412889,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2022-02-03T21:30:55.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":5250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F10","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2022 and provided the reporting person remains in continuous service through January 31, 2023."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F10","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2022 and provided the reporting person remains in continuous service through January 31, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2022 and provided the reporting person remains in continuous service through January 31, 2023."}],"balance_after":5250,"derivative":{"exercise_date":"2023-01-31","underlying":"Common Stock","underlying_shares":5250},"source":{"system":"sec-edgar","filing":"0001562180-22-001105","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022001105/primarydocument.xml","form_type":"4"}},{"id":2412888,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-03T21:30:55.000Z","date":"2022-02-01","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on January 30, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on January 30, 2023, provided the reporting person remains in continuous service on each vesting date."}],"balance_after":32468,"derivative":{"exercise_price":14.19,"expiration_date":"2029-01-30","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001562180-22-001105","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022001105/primarydocument.xml","form_type":"4"}},{"id":2412887,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-02-03T21:30:55.000Z","date":"2022-02-03","kind":"sale","acquired":false,"shares":947,"price":49.0347,"value":46435.8609,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Shares of Issuer's common stock sold to cover the reporting person's tax obligation in connection with the conversion of the Performance-Based Restricted Stock Units disclosed herein."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $48.78 to $49.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":28235,"source":{"system":"sec-edgar","filing":"0001562180-22-001105","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022001105/primarydocument.xml","form_type":"4"}},{"id":2412886,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-02-03T21:30:55.000Z","date":"2022-02-03","kind":"sale","acquired":false,"shares":17737,"price":48.2103,"value":855106.0911,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Shares of Issuer's common stock sold to cover the reporting person's tax obligation in connection with the conversion of the Performance-Based Restricted Stock Units disclosed herein."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $47.76 to $48.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":29182,"source":{"system":"sec-edgar","filing":"0001562180-22-001105","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022001105/primarydocument.xml","form_type":"4"}},{"id":2412885,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-02-03T21:30:55.000Z","date":"2022-02-03","kind":"exercise","acquired":true,"shares":36919,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":46919,"source":{"system":"sec-edgar","filing":"0001562180-22-001105","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022001105/primarydocument.xml","form_type":"4"}},{"id":2412884,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-02-03T21:30:55.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":21000,"source":{"system":"sec-edgar","filing":"0001562180-22-001105","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022001105/primarydocument.xml","form_type":"4"}},{"id":2412883,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-02-03T21:30:55.000Z","date":"2022-02-01","kind":"sale","acquired":false,"shares":400,"price":49.695,"value":19878.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $49.66 to $49.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001562180-22-001105","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022001105/primarydocument.xml","form_type":"4"}},{"id":2412882,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-02-03T21:30:55.000Z","date":"2022-02-01","kind":"sale","acquired":false,"shares":13853,"price":49.0665,"value":679718.2245,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $48.66 to $49.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":10400,"source":{"system":"sec-edgar","filing":"0001562180-22-001105","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022001105/primarydocument.xml","form_type":"4"}},{"id":2412881,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-02-03T21:30:55.000Z","date":"2022-02-01","kind":"sale","acquired":false,"shares":3730,"price":48.2572,"value":179999.356,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $47.66 to $48.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":24253,"source":{"system":"sec-edgar","filing":"0001562180-22-001105","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022001105/primarydocument.xml","form_type":"4"}},{"id":2412880,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-02-03T21:30:55.000Z","date":"2022-02-01","kind":"sale","acquired":false,"shares":2017,"price":46.828,"value":94452.076,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $46.475 to $47.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":27983,"source":{"system":"sec-edgar","filing":"0001562180-22-001105","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022001105/primarydocument.xml","form_type":"4"}},{"id":2412879,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-02-03T21:30:55.000Z","date":"2022-02-01","kind":"exercise","acquired":true,"shares":20000,"price":14.19,"value":283800.0,"ownership":{"direct":true},"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001562180-22-001105","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022001105/primarydocument.xml","form_type":"4"}},{"id":2429710,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-20T21:13:21.000Z","date":"2022-01-18","kind":"exercise","acquired":false,"shares":3718,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on July 21, 2017, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of July 21, 2017, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.42,"expiration_date":"2027-08-25","underlying":"Common Stock","underlying_shares":3718},"source":{"system":"sec-edgar","filing":"0001562180-22-000563","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022000563/primarydocument.xml","form_type":"4"}},{"id":2429709,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-20T21:13:21.000Z","date":"2022-01-18","kind":"exercise","acquired":false,"shares":5477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on March 30, 2018, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of March 30, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable."}],"balance_after":23444,"derivative":{"exercise_price":1.63,"expiration_date":"2028-03-30","underlying":"Common Stock","underlying_shares":5477},"source":{"system":"sec-edgar","filing":"0001562180-22-000563","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022000563/primarydocument.xml","form_type":"4"}},{"id":2429708,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-20T21:13:21.000Z","date":"2022-01-18","kind":"exercise","acquired":false,"shares":10805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on January 30, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on January 30, 2023, provided the reporting person remains in continuous service on each vesting date."}],"balance_after":52468,"derivative":{"exercise_price":14.19,"expiration_date":"2029-01-30","underlying":"Common Stock","underlying_shares":10805},"source":{"system":"sec-edgar","filing":"0001562180-22-000563","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022000563/primarydocument.xml","form_type":"4"}},{"id":2429707,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-01-20T21:13:21.000Z","date":"2022-01-18","kind":"sale","acquired":false,"shares":2046,"price":52.6063,"value":107632.4898,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $52.46 to $53.36. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001562180-22-000563","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022000563/primarydocument.xml","form_type":"4"}},{"id":2429706,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-01-20T21:13:21.000Z","date":"2022-01-18","kind":"sale","acquired":false,"shares":3886,"price":51.681,"value":200832.366,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $51.425 to $52.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":12046,"source":{"system":"sec-edgar","filing":"0001562180-22-000563","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022000563/primarydocument.xml","form_type":"4"}},{"id":2429705,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-01-20T21:13:21.000Z","date":"2022-01-18","kind":"sale","acquired":false,"shares":9756,"price":50.8044,"value":495647.7264,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $50.40 to $51.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":15932,"source":{"system":"sec-edgar","filing":"0001562180-22-000563","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022000563/primarydocument.xml","form_type":"4"}},{"id":2429704,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-01-20T21:13:21.000Z","date":"2022-01-18","kind":"sale","acquired":false,"shares":4312,"price":49.7281,"value":214427.5672,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $49.35 to $50.305. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":25688,"source":{"system":"sec-edgar","filing":"0001562180-22-000563","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022000563/primarydocument.xml","form_type":"4"}},{"id":2429703,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-01-20T21:13:21.000Z","date":"2022-01-18","kind":"exercise","acquired":true,"shares":3718,"price":1.42,"value":5279.56,"ownership":{"direct":true},"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001562180-22-000563","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022000563/primarydocument.xml","form_type":"4"}},{"id":2429702,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-01-20T21:13:21.000Z","date":"2022-01-18","kind":"exercise","acquired":true,"shares":5477,"price":1.63,"value":8927.51,"ownership":{"direct":true},"balance_after":26282,"source":{"system":"sec-edgar","filing":"0001562180-22-000563","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022000563/primarydocument.xml","form_type":"4"}},{"id":2429701,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-01-20T21:13:21.000Z","date":"2022-01-18","kind":"exercise","acquired":true,"shares":10805,"price":14.19,"value":153322.95,"ownership":{"direct":true},"balance_after":20805,"source":{"system":"sec-edgar","filing":"0001562180-22-000563","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218022000563/primarydocument.xml","form_type":"4"}},{"id":2698220,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-24T20:45:53.000Z","date":"2021-05-21","kind":"exercise","acquired":false,"shares":5875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on March 30, 2018, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of March 30, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable."}],"balance_after":28921,"derivative":{"exercise_price":1.63,"expiration_date":"2028-03-30","underlying":"Common Stock","underlying_shares":5875},"source":{"system":"sec-edgar","filing":"0001562180-21-003716","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218021003716/primarydocument.xml","form_type":"4"}},{"id":2698219,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-24T20:45:53.000Z","date":"2021-05-21","kind":"exercise","acquired":false,"shares":991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on July 5, 2017, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of July 5, 2017, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable."}],"balance_after":10934,"derivative":{"exercise_price":1.32,"expiration_date":"2027-07-05","underlying":"Common Stock","underlying_shares":991},"source":{"system":"sec-edgar","filing":"0001562180-21-003716","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218021003716/primarydocument.xml","form_type":"4"}},{"id":2698218,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-24T20:45:53.000Z","date":"2021-05-20","kind":"exercise","acquired":false,"shares":5142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on July 5, 2017, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of July 5, 2017, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable."}],"balance_after":11925,"derivative":{"exercise_price":1.32,"expiration_date":"2027-07-05","underlying":"Common Stock","underlying_shares":5142},"source":{"system":"sec-edgar","filing":"0001562180-21-003716","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218021003716/primarydocument.xml","form_type":"4"}},{"id":2698217,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-24T20:45:53.000Z","date":"2021-05-20","kind":"exercise","acquired":false,"shares":9701,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on May 23, 2017, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of May 23, 2017, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable."}],"balance_after":1616,"derivative":{"exercise_price":1.32,"expiration_date":"2027-05-23","underlying":"Common Stock","underlying_shares":9701},"source":{"system":"sec-edgar","filing":"0001562180-21-003716","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218021003716/primarydocument.xml","form_type":"4"}},{"id":2698216,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-24T20:45:53.000Z","date":"2021-05-20","kind":"exercise","acquired":false,"shares":28291,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on January 30, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on January 30, 2023, provided the reporting person remains in continuous service on each vesting date."}],"balance_after":63273,"derivative":{"exercise_price":14.19,"expiration_date":"2029-01-30","underlying":"Common Stock","underlying_shares":28291},"source":{"system":"sec-edgar","filing":"0001562180-21-003716","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218021003716/primarydocument.xml","form_type":"4"}},{"id":2698215,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-05-24T20:45:53.000Z","date":"2021-05-21","kind":"sale","acquired":false,"shares":6866,"price":55.2234,"value":379163.8644,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $55.00 to $55.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001562180-21-003716","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218021003716/primarydocument.xml","form_type":"4"}},{"id":2698214,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-05-24T20:45:53.000Z","date":"2021-05-21","kind":"exercise","acquired":true,"shares":5875,"price":1.63,"value":9576.25,"ownership":{"direct":true},"balance_after":16866,"source":{"system":"sec-edgar","filing":"0001562180-21-003716","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218021003716/primarydocument.xml","form_type":"4"}},{"id":2698213,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-05-24T20:45:53.000Z","date":"2021-05-21","kind":"exercise","acquired":true,"shares":991,"price":1.32,"value":1308.12,"ownership":{"direct":true},"balance_after":10991,"source":{"system":"sec-edgar","filing":"0001562180-21-003716","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218021003716/primarydocument.xml","form_type":"4"}},{"id":2698212,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-05-24T20:45:53.000Z","date":"2021-05-20","kind":"sale","acquired":false,"shares":24618,"price":55.0465,"value":1355134.737,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $54.855 to $55.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001562180-21-003716","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218021003716/primarydocument.xml","form_type":"4"}},{"id":2698211,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-05-24T20:45:53.000Z","date":"2021-05-20","kind":"sale","acquired":false,"shares":18516,"price":54.4537,"value":1008264.7092,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $53.83 to $54.825. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":34618,"source":{"system":"sec-edgar","filing":"0001562180-21-003716","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218021003716/primarydocument.xml","form_type":"4"}},{"id":2698210,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-05-24T20:45:53.000Z","date":"2021-05-20","kind":"exercise","acquired":true,"shares":5142,"price":1.32,"value":6787.44,"ownership":{"direct":true},"balance_after":53134,"source":{"system":"sec-edgar","filing":"0001562180-21-003716","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218021003716/primarydocument.xml","form_type":"4"}},{"id":2698209,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-05-24T20:45:53.000Z","date":"2021-05-20","kind":"exercise","acquired":true,"shares":9701,"price":1.32,"value":12805.32,"ownership":{"direct":true},"balance_after":47992,"source":{"system":"sec-edgar","filing":"0001562180-21-003716","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218021003716/primarydocument.xml","form_type":"4"}},{"id":2698208,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-05-24T20:45:53.000Z","date":"2021-05-20","kind":"exercise","acquired":true,"shares":28291,"price":14.19,"value":401449.29,"ownership":{"direct":true},"balance_after":38291,"source":{"system":"sec-edgar","filing":"0001562180-21-003716","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218021003716/primarydocument.xml","form_type":"4"}},{"id":2740523,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-23T19:50:21.000Z","date":"2021-04-21","kind":"exercise","acquired":false,"shares":15103,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on January 30, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on January 30, 2023, provided the reporting person remains in continuous service on each vesting date."}],"balance_after":91564,"derivative":{"exercise_price":14.19,"expiration_date":"2029-01-30","underlying":"Common Stock","underlying_shares":15103},"source":{"system":"sec-edgar","filing":"0001562180-21-002932","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218021002932/primarydocument.xml","form_type":"4"}},{"id":2740522,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":44223,"kind":"person","name":"Dearen Danny L.","position":1,"cik":"0001756438","reported_name":"Dearen Danny L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-23T19:50:21.000Z","date":"2021-04-21","kind":"exercise","acquired":false,"shares":9897,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on July 21, 2017, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of July 21, 2017, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable."}],"balance_after":3718,"derivative":{"exercise_price":1.42,"expiration_date":"2027-08-25","underlying":"Common Stock","underlying_shares":9897},"source":{"system":"sec-edgar","filing":"0001562180-21-002932","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1603756/000156218021002932/primarydocument.xml","form_type":"4"}}],"next_cursor":"2021-04-23T19:50:21.000000Z,2740522"}